Production (Stage)
NuGen Medical Devices Inc.
NGMD.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 81.40K | 297.00K | 389.90K | 10.90K | 35.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 81.40K | 297.00K | 389.90K | 10.90K | 35.20K |
| Cost of Revenue | 36.40K | 136.30K | 198.20K | 4.20K | 15.60K |
| Gross Profit | 45.00K | 160.70K | 191.70K | 6.70K | 19.50K |
| SG&A Expenses | 520.50K | 667.80K | 1.64M | 381.60K | 992.50K |
| Depreciation & Amortization | 109.80K | 113.00K | 114.00K | 116.80K | 127.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 666.80K | 917.00K | 1.95M | 502.70K | 1.14M |
| Operating Income | -585.30K | -620.00K | -1.56M | -491.80K | -1.10M |
| Income Before Tax | 1.09M | 361.70K | -2.16M | -694.90K | -1.35M |
| Income Tax Expenses | 2.70K | -2.80K | 7.90K | -- | -- |
| Earnings from Continuing Operations | 1.09M | 364.50K | -2.17M | -694.90K | -1.35M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.09M | 364.50K | -2.17M | -694.90K | -1.35M |
| EBIT | -585.30K | -620.00K | -1.56M | -491.80K | -1.10M |
| EBITDA | -475.50K | -507.00K | -1.45M | -379.70K | -987.30K |
| EPS Basic | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 226.47M | 219.46M | 217.32M | 215.88M | 204.98M |
| Average Diluted Shares Outstanding | 226.47M | 219.46M | 217.32M | 215.88M | 204.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |